pharmaceutical market intelligence Archives - Business Intelligence

Tag: pharmaceutical market intelligence

Pharma secondary packaging market

Infiniti’s Competitive Intelligence Solution for A Prominent Company in The Pharma Secondary Packaging Market: Exploring Key Packaging Innovations And competitive landscape Insights

In pharmaceuticals, secondary packaging constitutes the packaging which does not come in direct contact with the dosage form. Pharma secondary packaging is becoming widely adopted and essential as they offer critical functionalities, such as, for physical and barrier protection, secondary containment, adherence to regulations, and consumer safety. It also creates a buffer and protects primary packages from each other during transportation.

Business challenge

A prominent pharmaceutical company headquartered in San Francisco, CA sought to explore the changing trends in the secondary pharma packaging market by focusing the research on major design/technology innovations and best practices adopted by leading players in the pharma secondary packaging market. Through the engagement, the client wanted to support their future packaging developments and track industry trends over time. By leveraging Infiniti’s competitive intelligence solution, the pharmaceutical company wanted to understand the competitor landscape in the US and European pharma secondary packaging market, new features of secondary packaging being incorporated by competitors, product portfolio descriptions, and competitor strategies to promote adherence.   

Want comprehensive insights into the market drivers, challenges, key industry players, and more in the pharma secondary packaging market? Request a complimentary proposal.

Our Approach

Experts at Infiniti Research started by delving deeply into the pharma secondary packaging market transformation over the past decade in the US and Europe. This involved a well-balanced combination of primary and secondary research. Telephonic discussions were undertaken with over 45 respondents with expertise in the development, sales, marketing, and usage of products and services related to secondary packaging market such as pharmaceutical packaging specialists, packaging engineers, and packaging development experts. The secondary research undertaken by our analysts included comprehensive research materials from company websites, industry news CPA, HCPC, CHPA, packaging digest, and public database.

Through extensive competitive intelligence study and research methodologies, experts at Infiniti Research were able to identify the top pharma secondary packaging designs that are predominantly used. This includes medication adherence packaging, extended labels, and increasing use of sustainable materials in pharma secondary packaging. Furthermore, Infiniti’s competitor landscape assessment also identified some of the key competitors in the US and Europe, their respective packaging initiatives, and critical initiative undertaken to promote adherence.

With a focus to ensure product integrity, better manufacturing efficiency, and enhancing customer satisfaction, experts at Infiniti Research have identified that companies are developing innovative technologies such as thermochromic indicators and contemporary cartons designs. Furthermore, with Infiniti’s recommendation, the client adopted robotics and process automation that significantly improves production output, lowers operating cost, and enhances worker safety.

Business Impact

By leveraging Infiniti’s competitive intelligence solution, the client was able to successfully track their key market competitors and identify some of the most innovative and viable trends in the pharma secondary packaging market. Apart from this client was also able to:

  • Increase investments on their primary and secondary packaging lines by adopting technologies which result in faster turn-around time, fewer errors, and higher adaptability to incorporate and reproduce design changes
  • Collaborate with the CPO to formulate innovative packaging designs which are senior-friendly, child- resistant, medication adherence promoting, and offers unique dispensing mechanisms
  • Expedite early market entry for biologics and personalized medicine by identifying advancements such as 3D printing in pharmaceutical packaging
  • Reduce operational cost by 30% within this first quarter by adopting RPA into packaging operations
  • Focus on packaging designs that are cost-effective and have shorter production turnaround times
  • Incorporate adherence features in the secondary packaging design to help practitioners promote the use of the drugs to the patients
  • Build an effective planning and production process to minimize packaging errors and prevent product recalls, saving the company over $1.2 million within six months

For similar engagements for your business, get in touch with an industry expert

pharma M&A

Capturing Value from Pharma M&A: Critical Considerations for Success

The pharmaceutical industry is one of the major sectors that is actively involved in huge mergers and acquisition (M&A) deals, both in terms of numbers of deals and the amount of money spent. Most companies in the sector, especially the big pharma consider pharma M&A as a major factor to bolster innovation and overall growth. A recent research by our pharma industry experts shows that revenues coming from innovations sourced outside of Big Pharma is currently stands at over 45%. Over the years, several large, game-changing deals have continuously and profoundly changed the competitive landscape of the sector, while smaller yet significant transactions remain an integral part of pharma industry operations.

Why Pharma M&A is a driver of strategic repositioning?

Pharma M&A has become a common practice for companies that have non-diverse pipelines or have top revenue drugs that are nearing patent expiration and subsequent generic erosion. According to industry experts at Infiniti Research, some of key reasons why companies favor pharma M&A include:

  • The critical size requirements across various market segments have increased exponentially over the years. At this rate, it becomes nearly impossible for a single company for companies to survive on their own. This made strategic pharma M&A a necessity for most companies
  • Large mergers in the pharma industry allow bundling of sub-critical businesses, and thereby change the culture and to build new platforms
  • Another motivation for pharma M&A is to capture annual cost synergies by scaling up

For more insights on our portfolio of services for companies in the pharma industry

Consideration for successful M&A

Achieving Successful Integration Post Pharma M&A

Approximately only 60% of pharma merger deals succeed in the long run. A successful merger is one wherein the resulting company achieves the strategic intentions driving the merger when the deal was initially formed. Mergers that fail often show traits including focusing more attention on back-office integration, cost control, and systems consolidation.

Creating business synergies

Revenue increases during pharma M&A can often more difficult to achieve and take longer than expected. During pharma mergers and acquisitions teams must develop strategies such as the degree to which the existing portfolios need to be rationalized, how teams can be used to increase efficiency, how salesforce can be consolidated to remove overlap, and how the projects of each of the brands can be enhanced.

Defining the integration strategy

The successful integration of two companies largely depends on having a consistent approach with strategic intent. Guiding principles, priorities, and governance must reflect the logic behind the merger. A reliable integration strategy must be efficient in articulating both financial and nonfinancial goals, as well as risk-mitigation strategies.

Request a free proposal for more insights on how we can support your pharma M&A efforts.

pharmaceutical market research

Pharmaceutical Market Research: A Linchpin for Success in the Pharma Industry

Pharmaceutical companies are experiencing an industry slowdown. Amidst this, many players in the sector are seeking to transform their R&D engine into a source of competitive advantage in order to thrive. In such cases, effective pharmaceutical market research is paramount. Furthermore, current medicines are reaching saturation levels, making it even more crucial for pharma companies to invest in better drug development through comprehensive pharmaceutical market research. To gain reliable results and understand the actual needs of the target consumers, pharmaceutical market research must encompass data relating to potential success rates for new drugs as well as determine what factors affect pharma sales. Pharmaceutical market research ideally comprises early, pre-launch, launch, and post-launch market research.

If you’re part of the pharmaceutical or life science industries, you’ve probably already felt the effects of an industry that is slowing down. Want to know how our services can help you navigate challenges in the pharmaceutical industry?

Why is pharmaceutical market research important?

No matter how much companies in the pharma industry invest into a new drug development or how innovative the drug is, it becomes completely ineffective if the drug does not satisfy the needs of the target audience. Pharmaceutical market research provides insights into the demands in the target market and how to enhance the overall healthcare market experience. Pharma market research also helps in:

  • Understanding the market and competition
  • Targeting the right customers
  • Designing a unique value proposition
  • Determining the most profitable market strategy
  • Testing the product efficacy
  • Tracking the drug cycle

Essentials for effective pharmaceutical market research

pharmaceutical market researchGather customer feedback

It is an integral part of pharmaceutical market research to conduct a wide variety of surveys and research studies across all customer types to help identify and prioritize which issues will have the biggest impact on the company’s success. This includes physician satisfaction surveys, product satisfaction surveys, and patient pre-and post-clinical trial surveys.

The pharmaceutical industry is quite different from other consumer lead industries. Therefore, pharmaceutical market research forms the basis for everything from product development to marketing. Get in touch with our experts to know more about our pharmaceutical market research services.

Broad horizons

Although it may be easy for organizations and researchers to look to large companies for data, it is always advisable to consider bringing in data from small life science organizations as well. The more data gathered with the use of surveys and other data collection tools, the more accurate will be the business decisions.

Assess the market thoroughly

This involves picking the right environment in which to market a drug is critical. Disease patterns, political turmoil, economic stability, and market size/segmentation and operating conditions are just a few of the key factors affecting a company’s overall success with a product. Pharmaceutical market research can highlight any obstacles or opportunities that might disturb or encourage favorable outcomes.

Monitor customer feedback at different touchpoints

Provide a variety of ways for customers to share their comments and offer multiple feedback channels to improve both the quantity and quality of the feedback received. Ensure that customer sentiment is measured and monitored across all consumer support channels, as this kind of feedback is often provided ‘in the moment’ when opinions shared are most accurate. Moreover, feedback can also make a strong contribution to the development and evaluation of new initiatives, so remember to reference insight gathered when considering a new project.

Compliance and regulatory requirements

It is not only important to collaborate with consultants and various business leaders in relevant industries while collecting data, but also vital to get their input once the data is collected as well. Different perspectives, educational, and professional backgrounds provide insight into data analysis that may be helpful when moving ahead with pharmaceutical market research.

Learn more about our pharmaceutical market research services

pharmaceutical industry

Illuminating the impact of Brexit on Europe’s Pharmaceutical industry

Pharmaceutical industry products are in the list of top five products that are most imported and exported from the UK to the EU and vice versa.

Brexit can have several implications of Europe’s pharmaceutical industry. From product development to market approval to the shipping of medicines and medical devices, pharmaceutical companies can expect to be affected in a broad range of areas. Companies in the pharmaceutical industry in the UK will have to manage the impact of Brexit carefully to prevent some of the negative aspects. However, uncertainty will have adverse effects on pharmaceutical and life sciences companies in other European countries as well. Experts at Infiniti predict how Brexit will affect life science and pharmaceutical industry.

Rising demand for personalized treatments, an ageing population, and the rise of new manufacturing technologies are some of the primary growth opportunities for the UK pharmaceutical sector. Request a free proposal to know how our solutions can help you stay prepared to cope with the market trends and changes.

Relocating European Medicines Agency (EMA)

One of the key pharmaceutical industry market access challenges that Brexit brings along with it, irrespective of the path it takes is related to the future location of the European medicines agency. Since its inception in 1995, EMA had been located in London. However, the Netherlands has now won the bid to host new EMA headquarters post-Brexit. With the EMA headquarters soon moving to Amsterdam, they may implement several changes to rules for medicinal products that are developed and tested in the UK. However, the extent of Brexit-induced changes to the pharmaceutical industry has yet to be decided.

Movement of people and pharma products

Pharma products form a considerable part of goods that are exported to and from the UK. Any post-Brexit hurdles to the free movement of goods could mean trouble for those supplies, potentially leading to temporary drug shortages. This is especially true in the case of drugs such as medicinal insulin that are not manufactured in the UK nor is it easily stored, as it requires temperature-controlled conditions. In order to reduce the risk of drug shortages in the case of a no-deal Brexit, the British government has asked pharmaceutical companies to add a minimum of six weeks’ worth of additional backup supply of medicines to their usual buffer stocks by the exit date, and to ensure that contingency plans were in place for drugs with shorter shelf lives. However, it is not only the movement of medicines that’s at risk. As the possibility of stricter rules regarding the flow of people between the UK and the EU looms, companies in the pharmaceutical industry are concerned about their ability to attract talent from outside Britain in the future. It is vital that pharmaceutical companies to still be able to access the best talent from around the world.

Emerging markets represent an exceptional opportunity for the pharmaceutical sector. Get in touch with our experts for more insights on how to capture the true value of the pharmaceutical market.

Change in the UK’s contribution to drug regulation

UK plays a major role in drug regulation in the EU through the work of the Medicines and Healthcare Products Regulatory Agency (MHRA). The UK frequently serves as rapporteur/co-rapporteur in the EU’s centralized procedure and as the reference member state in the decentralized procedure. It will prove to be a challenging task to replace the MHRA’s capacity and expertise, particularly if the timetable for reform is aggressive.

 

Safe supply of blood and organs

Another pressing challenge faced by companies in the pharmaceutical industry due to Brexit is linked to ensuring blood and blood products are safe. If there is a no-deal Brexit, the EU Blood Directives will not apply to the UK and it will be considered a third country by the EU regarding sharing blood, blood components, and information. The UK Government has declared that in the event of a no-deal, the current blood safety and quality standards for blood and blood components will remain the same, and therefore adhere to EU standards, allowing them to be imported into the EU. Similarly, the UK Government has laid out its provisions for ensuring the supply, as well as the safety and quality, of organs, tissues, and cells in the event of a no-deal. The UK would no longer be part of the EU Organ and EU Tissues and Cells directives, however, relevant UK establishments, such as stem cell laboratories and fertility clinics, would be required to work to the same standards. These organizations would need to individually agree on import and export of the products with EU and EEA authorities and establishments.

Learn more about Infiniti’s solutions for the pharmaceutical industry.

Recent Posts

Pharmaceutical manufacturing

IoT in Pharmaceutical Manufacturing: How it will Make a Difference

Internet of things (IoT) has the power to revolutionize pharmaceutical manufacturing in everything ranging from drug discovery to remote patient access and monitoring. Top pharma companies around the globe are increasingly adopting IoT technologies in their manufacturing plants in an effort to achieve optimization and improve process efficiency. Earlier, different data formats for different processes in a pharmaceutical manufacturing plant made data access and interpretation a significant challenge for effective communication. IoT technologies enable standardization within a pharmaceutical manufacturing plant by effectively connecting network, equipment, and systems across the plant. Furthermore, Pharma companies can also use IoT technologies to gain access to real-time data and visibility of operations through the entire manufacturing process. Here’s a detailed look on how IoT will transform pharmaceutical manufacturing.

Despite technological advancements, the pressing matter pharma companies have to address is how to achieve more control over their operations within and outside the facilities to remain competitive, optimize time-to-market, avoid shipment delays, and reduce the waste. Request a free proposal to know we can help overcome this dilemma.

IoT in Pharmaceutical Manufacturing

Pharmaceutical manufacturingIndustrial mechanics and maintenance

Although the use of industrial monitoring devices are already widespread in the pharmaceutical industry, real-time status information is yet to be widely available. Using pharma IoT monitoring sensors companies can instantaneously feed all relevant facility data into a single dashboard, alerting a supervisor in case of any abnormal conditions or urgent maintenance requirements. IoT in pharmaceutical manufacturing will also enable handling critical conditions remotely.

Managing pharma supply chain

Once the drugs leave the manufacturing plant, they travel through different modes of transport and may be subject to varying temperatures and weather conditions. Although in most cases care is undertaken to maintain the packages within the prescribed temperatures, chances of variations during transit cannot be completely ruled out. IoT can be helpful in such situations to provide real-time data to manufacturers every step of the way with improved supply chain visibility. The temperature changes or any damage to the products will be immediately notified to the manufacturers and determine whether the drugs are fit to sell or not.

In the pharmaceutical industry, mistakes have serious consequences, so progress will always be slow and cautious. Get in touch with our experts to learn how our solutions can help companies in the pharmaceutical industry.

Controlling drug manufacturing environment

In pharmaceutical manufacturing, sub-optimal environmental conditions can often prove to be fatal. However, this obstacle can be easily handled with the help of IoT. Pharma IoT establishes transparency in drug production and storage environment by allowing multiple sensors to monitor environmental indicators such as temperature, humidity, radiation, and light in real-time.

Learn more about Infiniti’s solutions for the pharma industry

Market Assessment

Pharma 2020: Key Pharma Industry Trends to Watch Out For

The pharma industry is undergoing a myriad of changes. Therefore, success in today’s pharmaceutical marketplace largely depends on companies’ ability to continually reassess strategic direction, move with agility, and anticipate and adapt to changes. Businesses must not only keep a close watch on the pharma industry trends, but equal emphasis should be given to tackling the upcoming challenges. Some of the key challenges identified during our pharma industry analysis include:

  • Increasing instances of chronic diseases are placing greater pressure on the healthcare budgets
  • Healthcare policy makers are increasing pressure on doctors regarding what to prescribe
  • Growing demand for medicines in emerging economies
  • Regulators are becoming increasingly cautious while approving new and innovative medicines
  • Pharma-economic performance is measured in order to insist on outcome-based pricing

How to overcome these challenges?

All you need a market intelligence solutions provider to guide you with the right solutions for business. Request a free brochure to gain insights into Infiniti’s advanced solutions for the pharma industry.

Pharma industry trends

Despite these challenges, there are several exciting pharma industry trends underway. Infiniti Research’s pharma industry analysis reveals the following trends that companies in this sector must gear up for:

Prevention over treatment

 One of the key pharma industry trends that are expected to go mainstream is the idea of prevention over treatment. Governments across the globe are backing this, especially in the case of chronic diseases. Global pharmaceutical industry analysis suggests that there is an unprecedented amount of supply in prevention supplements and pills around the world. If certain chronic diseases cannot be treated, some of its symptoms and fatal consequences can be prevented through such initiatives.

Reverse innovation

Reverse innovation refers to any innovation which is adopted first by emerging economies and then distributed globally. Pharma industry trends of the future such as reverse innovation provide answers to various challenges faced by companies in the pharma industry including the rising research costs, patent expiration, and consequent revenue declines, and huge costs in bringing a drug to market.

Nanotechnology

Nanotechnology is one of the most notable recent trends in the pharmaceutical industry. Nanotechnology is a scientific, multi-disciplinary effort that involves the creation and utilization of essence systems on a nanometer scale. An important application of this innovation is in the form of ‘Nano-medicine’. Pharma industry experts at Infiniti Research believe nanotechnology to be one of the most impressive pharma industry trends and will unleash several breakthroughs in medicine, diagnosis, and genetic engineering. A key example of an innovative nanomedicine is that of Genexol-PM which is an anti-cancer drug used to fight breast cancer and non-small lung cancer.

Customization or personalized medicine

People around the globe are known to have genetic differences, however, all of us consume similar medicine that has been designed for millions of people. However, this trend is about to change in the near future. Personalized medicine is expected to become one of the most favored pharma industry trends in the future. The drugs will be customized based on the patient’s examination reports and medical records. Though it would take some time for this to become full-fledged in the pharma industry, such trends in the pharma industry will provide enhanced treatment to the patients.  

How can Infiniti’s trend analysis solutions help companies in the pharma industry to keep a close watch on the recent market trends and revamp their strategies to stay at par with top players in the market? Request a proposal to find out.

3D printing

3D printers are under rapid development. The adaptation of this technology in the pharma industry will enable companies in the sector to print the necessary medicines as per requirements. In 2015, the first FDA approved a drug called Spritam was printed. This drug is used to treat epilepsy. This pill was made 3D printing several layers of the powdered drug, binding the layers of powder together, and blowing away the excess powder. The drug easily dissolves when compared to a traditional pill due to its unique structure. This is especially useful for cases where otherwise large, hard-to-swallow pills are prescribed.

Body sensors

Body sensors are breakthrough pharma industry trends that are all set to revamp patient-care and drug prescription. Wearables, integrated body chip, mini robots, and several other types of body sensors can obtain patient information and communicate the same immediately to the healthcare professionals. This can help them make quick and informed decisions regarding the drugs that need to be prescribed to the patient. These systems integrate living human cells with micro-engineering to help researchers and product development teams a new standard for predicting human response with greater precision.

Artificial intelligence

Artificial intelligence and cognitive computers help gather and classify large volumes of data in a matter of seconds. This solves the common problem that the drug discovery process is lengthy and expensive. These advanced technologies will also help pharma companies to run cognitive trials in lesser time. Which means drugs can be delivered to patients much earlier than before.

GET MORE INFO to know more about Infiniti’s solutions for business

Competitive Assessment Study on Filter Plates and Membranes Helps a Leading Manufacturer Assess the Market Shares of Top Global Players

Filter plates are primarily used for applications requiring liquid-solid separation, such as mining and mineral processing, chemical manufacturing, paint and pigments, and wastewater treatment, among others. Quality, higha2 durability, and precise specifications are the key attributes of filter plates and filter membranes as they are mostly used in specific industrial applications. A comprehensive range of plate types and materials including recessed filter plates, membrane plates, vacuum membrane filter plates are available for different types of industrial applications. Filter membranes are used to reduce the cake moisture content or shorten the filtration cycle time. There are two types of membrane plate designs – fixed membranes and replaceable membranes.

Filter membranes are typically used for both liquid and air filtration as they offer precisely controlled pore size distribution with increased strength and flexibility. This makes them well-suited for a broad range of applications such as basic research, environmental testing, and pharmaceutical as well as food and beverage industries. Moreover, standard and custom filter plate designs and filter press plates help improve cake dryness and washing efficiency to help combat abrasive conditions.

The Business Challenge

To obtain a precise understanding of the current and future market scenario and assess the market shares of topcapture global players, the client – a leading manufacturer of extruded and pressed thermoplastic materials for various industries – approached Infiniti to carry out a competitive assessment study on filter plates and filter membranes across the target region. The primary focus of this competitive assessment was to assess the size and growth rate of the market and to offer an in-depth analysis of the market trends, growth drivers, and the key challenges and their impact on the market size.

The scope of this competitive assessment involved offering actionable insights to the client on the market segments and understand market attractiveness in the respective segment to strategize the company’s growth plans across the target end-user segments – mining and minerals industry, chemical industry, food industry, and pharmaceutical industry. Additionally, our industry experts also offered an analysis of the key competitors to help the client gain a holistic overview of all the market-leading companies and their market size, product portfolio, target regions, and sales and marketing strategies. Infiniti’s experienced competitive assessment team conducted interviews and discussions with market stakeholders across the business landscape and value chain of the industrial filtration products market to access relevant information and insights, and ensure accuracy of the data.

Why Infiniti Research is the preferred partner for more than 55 Fortune 500 Companies

 

Infiniti Preferred Partner Graphic EditedSolution Offered and Business Impact

An experienced team of competitive assessment experts was assigned to this engagement to help clients gain an in-depth understanding of the overall filter plates and membranes market and analyze the various factors affecting theCapture2 growth of the market. To address the client’s specific category requirements, Infiniti’s competitive assessment team followed a comprehensive data analysis methodology consisting of qualitative and quantitive analysis. The information gathered through this process was utilized to design an analysis framework using multiple data analysis tools and software packages and implement a framework to gather valuable insights. Furthermore, after a thorough assessment of the relevance, efficiency, and impact of the gathered information, valuable insights were derived on the market’s growth prospects across the target region.

The experts also used a combination of multiple research methodologies of secondary research for building initial hypotheses and identifying key market stakeholders and business executives for primary research. Moreover, the research experts also referred to a broad range of public and proprietary databases through our network to obtain, organize, and analyze relevant published information, and develop contact details of market stakeholders. Secondary research also involved reviewing an extensive array of market research reports, white papers, magazines and publications, annual reports, websites of competitors, company publications, case studies, journals, news aggregators, and industry forums to obtain, organize, and analyze relevant published information. Additionally, to offer a detailed assessment of current and emerging market trends, our competitive assessment experts conducted interviews and discussions with market experts, business executives, and stakeholders from the filter plates and filter membranes market.

By the end of six weeks, the client was able to gain a clear understanding of the market across the target regions. Additionally, the client also derived numerous benefits in terms of understanding the target segment, the target regions, and the competitive landscape of the filter plates and filter membranes market.

Benefits of Our Integrated Approach

In a relatively short duration of six weeks, the client saw clear benefits from our relationship. The competitive assessment helped the client gain a complete overview of the current market scenario, including market size, trends, drivers, and challenges associated with filter plates and membranes. Additionally, with a better understanding of the competitors and their growth strategies, the client was able to devise a conducive strategy to benefit in terms of ROI.

Here are some of the key points appreciated by our clients

  • Dedicated Market Assessment Portal. A centralized platform for the collection, storing, processing, reporting, and dissemination of information with the specific purpose of assisting the decision-making process and developing actionable insights. This portal offers competitive assessments on quantitative and qualitative aspects on target markets, competitors, and end-users.
  • Collaborative learning. We leveraged the experience of our healthcare team and our technical capabilities to enable report-sharing and other collaborative features appreciated by client teams.
  • Database Access. Access to a patient database containing information about 60+ medical diseases and conditions, such as patients undergoing treatment, untreated patients, and patients with chronic conditions.
  • Interactive Dashboard. Using our portal-based solution for business professionals, we took a design-first approach to problem-solving and helped break through previously held assertions.
  • Value for Money. Infiniti’s dedicated competitive assessment team customizes reports to suit business requirements and offers the best insights for every dollar spent.

 

A must-read competitive assessment case study for strategy experts and decision makers looking to develop effective market entry strategies for filter plates and membranes.

 

capture2

 

 

Related Articles

Cosmetic packaging

Market Analysis and Assessment of Rheumatology Centers

Despite robust sales of rheumatology drugs and the positive impact of expanding geriatric population, the market for rheumatology therapeutics is undergoing a lean period due to the advent of biosimilars.  

Rheumatology is essentially a sub-specialty of internal medicine dedicated exclusively to patient care, research, and education in the avenues of rheumatic arthritis and autoimmune diseases. Hectic lifestyles, unhealthy eating habits, and a dearth of physical activity has led to an increasing number of individuals around the world suffering from joint and connective tissue problems. Experts believe rheumatic diseases are caused by a combination of genes and environmental factors. In general, having certain gene variants can increase a person’s susceptibility to rheumatic diseases, and factors in the environment may trigger the onset of the disease.

Rheumatology centers are medical centers committed to the treatment of rheumatic diseases and problems related to joints, soft tissues, and autoimmune and heritable connective tissue disorders. Some of the major rheumatica2 conditions are neck pain, back pain, osteoarthritis, and bursitis. Globally, rheumatology centers provide advanced and rationally based care to its patients and are involved in the research and developmental activities concerning early diagnosis and treatment. It provides a multidisciplinary setting for patient care, including physician and nursing services, diagnostic and therapeutic radiology, and physical and occupational therapy. Moreover, many rheumatology centers offer special programs for patients with osteoarthritis, rheumatoid arthritis, gout, and metabolic arthritis.

The Business Challenge

With an aim to identify future market opportunities, the client – one of the largest pharmaceutical companies in the world – approached Infiniti to engage in a market opportunity assessment to identify and profile the top rheumatology centers across North America and Europe. The scope of this engagement was to help the pharmaceutical and medical devices company develop a database of rheumatology centers within the target regions, which would be updated on a regular basis. The insights offered through this market opportunity study would function as a country-specific market map to identify potential market opportunities in specific countries.

The key objective of this market opportunity assessment was to develop a master database of major rheumatology centers across the US, Canada, UK, Germany, France, Italy, and Spain. The proposed master list of rheumatology centers would serve as a market map for each country and act as a decision support tool to determine the marketability of their medical devices and services in each country.

Additionally, Infiniti’s “market opportunity assessment” team tracked recent developments and innovations in the medical devices industry through journals and reached out to relevant stakeholders, including product users,capture industry experts, KOLs,  and procurement experts to assess their views on the market’s landscape. Our market opportunity assessment team also spoke to key stakeholders responsible for the sales and distribution of medical devices to gain insights on how the market would grow in the short and long term to validate the market opportunity assessment model developed for this segment.

Why Infiniti Research is the preferred partner for more than 55 Fortune 500 Companies

untitled

Solution Offered and Business Impact

To meet the specific category requirements of the leading pharmaceutical and medical devices manufacturer, our industry experts – who have extensive experience in healthcare, medical devices, and pharmaceutical verticals across the globe – followed a two-step research methodology. The approach involved an analysis of the major rheumatology centers for each country under focus and an assessment of the major profiles for rheumatology centers. Infiniti’sCapture2 strategy experts also referred to a variety of healthcare information sources to gather quality insights during each step of the research engagement. The insights garnered for this market opportunity assessment were obtained from an assessment of the rheumatology market and allied healthcare industry reports, medical databases and patient statistics, hospital reports, white papers, magazines and publications, publications of traders and distributors, and case-studies.

In a mere span of 14 weeks, the pharmaceutical company was able to gain insights into the market landscape for rheumatology centers within North America and Europe. The information obtained through this engagement also helped the client develop an effective market map to identify potential market opportunities.

To assess and address challenges specific to healthcare market space, Infiniti’s research specialists have developed a scrupulous proprietary database consisting of information on more than two million industry experts, physicians, key opinion leaders, doctors, medical technicians, end-users, and patients.

What do the clients appreciate about our approach?

In a relatively short period of time, just 14 weeks, the client saw clear benefits from our market opportunity assessment. The market opportunity services offered by Infiniti helped the pharmaceutical and medical device manufacturer augment their revenue potential by providing insights into how they can identify potential market opportunities for their products and services.

Here are some of the key points appreciated by our clients

  • Dedicated Market Opportunity Portal. A centralized platform for the collection, storing, processing, reporting, and dissemination of information with the specific purpose of assisting the decision-making process and developing actionable insights. This portal includes comprehensive information on quantitative and qualitative aspects on target markets, competitors and end-users.
  • Collaborative learning. We leveraged experience of our healthcare team and our technical capabilities to enable report-sharing and other collaborative features appreciated by client teams.
  • Database Access. Access to a patient database containing information about 60+ medical diseases and conditions, such as a patient undergoing treatment, untreated patients, and patients with chronic conditions.
  • Interactive Dashboard. Using our portal-based solution for healthcare professionals, we took a design-first approach to problem-solving and helped break through previously held assertions.
  • Value for Money. Infiniti’s dedicated client management team customizes reports to suit business requirements and offers the best insights for every dollar spent.

 

A must-read market opportunity assessment for strategy experts and decision makers looking to estimate the marketability of their products and services.

 

 

Request your free proposal now

 

Related Articles

 

product research

Market Analysis for Alzheimer’s Drugs

Business Challenge
A leading pharmaceutical company wanted to identify the potential for its Alzheimer’s drugs at a global level; it also wanted to assess the challenges that it could face during product launch.
Situation
The client wanted to quantify the potential for its new product at a global level. It also wanted to develop an understanding of the critical challenges that it could encounter when launching its products.
Approach
We conducted extensive primary and secondary research to determine the market’s size, trends, and key competitor brands. We also critically analyzed the possible challenges that the company could face when launching its products, in the form of regulatory compliance requirements.
Impact
The client gained a better understanding of the market and aligned its go-to market strategies accordingly. It was also able to restructure its launch strategies in alignment with the regulatory requirements of various target countries.
Market Entry Strategies

Market Opportunity Assessment for Parkinson’s Disease (PD) Medication

Business Challenge
A leading multinational healthcare company was interested in assessing the opportunities for its soon to be launched drugs for Parkinson’s Disease management.
Situation
The client wanted to identify the market gaps and assess the market potential, regulatory compliance requirements, and competitive landscape to develop appropriate market positioning strategies prior to launching its drugs.
Approach
We conducted two-phased research –an industry scan and comprehensive assessment of the PD medication market, followed by deep-dive analysis of the top three competitors’ products (both existing and planned).
Impact
The client gained an understanding of the market gaps and regulatory requirements in various geographies. It was also able to assess its competitors’ strategies to develop appropriate launch strategies for its own product.
Close
Infiti Logo

Hello there!

Contact us to know more about our cost-effective custom market research offerings to support efficient market penetration, new product launch, and devise strategies to monitor and outperform your competitors.

Cookie Policy

The Site uses cookies to record users' preferences in relation to the functionality of accessibility. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice